Who is sponsoring NCT05681494?

NCT05681494 is sponsored by Cairo University.

What drugs are being tested in NCT05681494?

Interventions in NCT05681494: Root canal treatment, Vital pulp therapy.

What condition does NCT05681494 study?

NCT05681494 studies Symptomatic Irreversible Pulpitis.

Is NCT05681494 still recruiting?

NCT05681494 is currently status unknown. Last updated 16 February 2023.

Last reviewed 2023-02-16 · How we verify

NCT05681494

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Assessment of Pain and Treatment Success After VPT Versus RCT in Mature Permanent Mandibular Molars With SIP: A RCT

Status unknown NA Last updated 16 February 2023

What this trial tests

NA trial testing Root canal treatment in Symptomatic Irreversible Pulpitis in 44 participants. Status unknown.

Timeline

26 February 2023

Primary endpoint
26 July 2023

26 June 2024

Quick facts

Lead sponsor	Cairo University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	44
Start date	26 February 2023
Primary completion	26 July 2023
Estimated completion	26 June 2024

Drugs / interventions tested

Root canal treatment
Vital pulp therapy

Conditions studied

Symptomatic Irreversible Pulpitis — all drugs for Symptomatic Irreversible Pulpitis →

Sponsor

Cairo University

Who can join

Adults 18 to 40, any sex, with Symptomatic Irreversible Pulpitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Assessment of postoperative pain and treatment success after vital pulp therapy versus root canal treatment in mandibular molar with signs and symptoms of irreversible pulpitis. the null hypothesis, there is no difference will be observed in the pain level and treatment success between two treatments.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Root canal treatment

Trials testing the same drug.

NCT07534943 — Effectiveness of Oleanolic Acid as Intracanal Medicament on Infectious/Inflammatory Contents in Teeth With Apical Period · NA · active not recruiting
NCT07375576 — Outcomes of Pulpotomy and Root Canal Treatment in Teeth With Symptomatic Irreversible Pulpitis · NA · recruiting
NCT07163975 — Complete Pulpotomy and Root Canal Treatment Patients With Irreversible Pulpitis With Type 2 Diabetes Mellitus · NA · recruiting
NCT06671743 — Premedication on Post-endodontic Pain · Phase 3 · recruiting
NCT06468085 — Evaluation of Pulpotomy Using Two Different Agents in Mature Anterior Teeth With Pulpitis · NA · not yet recruiting

Other recruiting trials for Symptomatic Irreversible Pulpitis

Currently open trials in the same condition.

NCT07410780 — Postoperative Pain After Root Canal Obturation Using Bioceramic and Calcium Hydroxide Sealers · NA · recruiting
NCT07290049 — Postoperative Pain After Pulpotomy in Children Using Calcium Silicate Cements With and Without Laser Therapy · NA · recruiting
NCT06640231 — The Effect of XP-Endo Finisher Activation of Bioceramic Sealer on Postoperative Pain in Mandibular First Molar With Symp · NA · recruiting
NCT06525844 — Regenerative Endodontic Therapy in Cases of Irreversible Pulpitis · NA · recruiting

Other Cairo University trials

Trials by the same sponsor.

NCT04155528 — Effect of Music Therapy on Postoperative Health Outcomes · NA · not yet recruiting
NCT07363239 — CBCT-Based Safety Distance for Implant Placement Near the Inferior Alveolar Canal · not yet recruiting
NCT07374575 — Egyptian Dental Professionals' Perspectives on the Oral Microbiome and Exosomes · not yet recruiting
NCT07381153 — In-Vitro Cytotoxicity Assessment of INOX (Nanoksa G Plus) Polymer Discs · not yet recruiting
NCT07375394 — 3D-Printed Extraoral Camera for Standardized Dental Photography · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05681494 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Cairo University
Last refreshed: 16 February 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05681494.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing